Table 3. Mean log reductions (c.f.u. ml⁻¹) among clinical isolates after 1 h incubation with 16PLL₁₀.

16PLL10concn	Species	Ref. no	Site	Underlying condition	Log reductionc.f.u. ml−1±SEM*
0.25 µM	A. baumannii	23AD06	BAL	–	1.17±0.22
	A. lwoffii	22AD05	Foot Ulcer	Diabetes	3.81±0.10
	E. cloacae	23AD01	BKA Wound	Diabetes/PVD	0.30±0.10
	E. faecium (VRE)	23AD04	Foot Ulcer	Diabetes/PVD	3.01±0.65†
	K. oxytoca	23AD11	Foot Ulcer	Diabetes	2.45±0.10
	P. aeruginosa	22AD01	Ankle Ulcer	PVD	1.30±0.12
	S. aureus (MRSA)	23AD02	Necrotic Toe	Diabetes	2.49±0.17
	S. aureus (MSSA)	23AD10	Foot Ulcer	Diabetes	3.22±0.55
	S. dysgalactiae	23AD09	Foot Ulcer	Diabetes/Chemotherapy	0.78±0.07
2.5 µM	A. baumannii	23AD06	BAL	–	4.96±0.11†
	E. cloacae	23AD01	BKA Wound	Diabetes/PVD	4.53±0.36†
	P. aeruginosa	22AD01	Ankle Ulcer	PVD	5.53±0.05†
	S. dysgalactiae	23AD09	Foot Ulcer	Diabetes/Chemotherapy	3.78±0.29

a *Values shown are the mean±SEM from assays carried out in triplicate on three separate occasions. Reaching limit of assay for some/all experiments at this concentration. BAL – Bronchoalveolar Lavage, BKA – Below Knee Amputation, PVD – Peripheral Vascular Disease

†Reaching limit of assay for some/all experiments at this concentration.

BALbronchoalveolar LavageBKAbelow knee amputationPVDperipheral vascular disease